We are live on ! Find out more
BCA

Benchmark Capital Advisors Portfolio holdings

AUM $101M Turnover 16.91%
1-Year Est. Return 0.8%
This Fund
S&P 500
This Quarter Est. Return
-11.15%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
–
AUM
$101M
AUM Growth
-$32.5M
Cap. Flow
-$16.1M
Cap. Flow %
-16.04%
Top 10 Hldgs %
35.51%
Holding
136
New
2
Increased
26
Reduced
56
Closed
21
Avg Time Held Equity + Options
3.5 years
Top 10 Avg Time Held Equity + Options
2.2 years
Top 20 Avg Time Held Equity + Options
2.5 years
Avg Time Held Equity only
3.5 years
Top 10 Avg Time Held Equity only
2.2 years
Top 20 Avg Time Held Equity only
2.5 years

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$4.43M
2
WBA icon
Walgreens Boots Alliance
WBA
+$2.06M
3
MDLZ icon
Mondelez International
MDLZ
+$1.66M
4
NFLX icon
Netflix
NFLX
+$1.09M
5
AVT icon
Avnet
AVT
+$1.03M

Sector Composition

Rank Sector Weight
1 Miscellaneous 18.98%
2 Real Estate 15.61%
3 Technology 13.31%
4 Healthcare 13.05%
5 Financials 11.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TEVA icon
51
Teva Pharmaceutical Industries
TEVA
$49.7B
$533K 0.53%
34,544
-7,000
-17% -$144K
2016 Q1
11 quarters
RGLD icon
52
Royal Gold
RGLD
$21B
$531K 0.53%
6,200
– –
2013 Q4
20 quarters
RWT icon
53
Redwood Trust
RWT
$336M
$527K 0.52%
34,966
– –
2013 Q2
22 quarters
CEMI
54
DELISTED
Chembio Diagnostics
CEMI
$515K 0.51%
90,929
-9,606
-10% -$70.8K
2017 Q2
6 quarters
BRK.B icon
55
Berkshire Hathaway Class B
BRK.B
$1.26T
$470K 0.47%
2,300
– –
2017 Q3
5 quarters
MS.PRA icon
56
Morgan Stanley Series A Preferred Stock
MS.PRA
$707M
$457K 0.45%
24,105
+400
+2% +$8.2K
2013 Q2
22 quarters
MET.PRA icon
57
MetLife Series A Preferred Stock
MET.PRA
$462M
$444K 0.44%
21,200
– –
2013 Q2
22 quarters
RDI icon
58
Reading International Class A
RDI
$43.3M
$416K 0.41%
28,600
-2,500
-8% -$37.5K
2013 Q2
22 quarters
DOC icon
59
Healthpeak Properties
DOC
$13.7B
$408K 0.41%
14,600
-2,300
-14% -$63.7K
2013 Q2
22 quarters
SRPT icon
60
Sarepta Therapeutics
SRPT
$1.62B
$398K 0.4%
3,650
-350
-9% -$43.8K
2013 Q2
22 quarters
SNY icon
61
Sanofi
SNY
$116B
$386K 0.38%
8,900
-400
-4% -$17.6K
2015 Q1
15 quarters
VTNR icon
62
DELISTED
Vertex Energy
VTNR
$368K 0.37%
360,969
-4,800
-1% -$7.2K
2013 Q2
22 quarters
VZ icon
63
Verizon
VZ
$192B
$367K 0.37%
6,536
+12
+0.2% +$681
2014 Q3
17 quarters
GLD icon
64
SPDR Gold Trust
GLD
$129B
$364K 0.36%
3,000
– –
2015 Q3
13 quarters
GE icon
65
GE Aerospace
GE
$337B
$359K 0.36%
9,896
-6,573
-40% -$297K
2013 Q2
22 quarters
VTI icon
66
Vanguard Morningstar Total Stock Market ETF
VTI
$676B
$357K 0.36%
2,795
+90
+3% +$12.4K
2013 Q2
22 quarters
CTSH icon
67
Cognizant
CTSH
$27.8B
$333K 0.33%
5,250
– –
2017 Q2
6 quarters
QQQ icon
68
Invesco QQQ Trust
QQQ
$454B
$332K 0.33%
2,155
+60
+3% +$10K
2015 Q3
13 quarters
PCI icon
69
DELISTED
PIMCO Dynamic Credit and Mortgage Income Fund
PCI
$324K 0.32%
15,400
– –
2014 Q4
16 quarters
MFA icon
70
MFA Financial
MFA
$584M
$312K 0.31%
11,675
-1,250
-10% -$35.1K
2013 Q2
22 quarters
MUC icon
71
BlackRock MuniHoldings California Quality Fund
MUC
$1.23B
$308K 0.31%
25,000
– –
2013 Q2
22 quarters
PTY icon
72
PIMCO Corporate & Income Opportunity Fund
PTY
$2.34B
$301K 0.3%
19,600
– –
2017 Q4
4 quarters
VNQ icon
73
Vanguard Real Estate ETF
VNQ
$38.5B
$297K 0.3%
3,980
-115
-3% -$9.06K
2013 Q4
20 quarters
VXX icon
74
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 2019
VXX
$293K 0.29%
+6,250
New +$231K
2018 Q4
0 quarters
GM.WS.B icon
75
CALL
DELISTED
General Motors Warrants
GM.WS.B
$292K 0.29%
18,346
– –
2015 Q3
13 quarters

Similar funds

Benchmark Capital Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Benchmark Capital Advisors held 136 positions worth $101M, down 24% from $133M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Benchmark Capital Advisors withdrew a net $16.1M in Q4 2018, closing 21 positions and reducing 56 holdings. Its most notable exit was Walgreens Boots Alliance, an estimated $2.06M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 19% of assets, up from 15% a quarter earlier, followed by Real Estate and Technology.

Against the trend, Benchmark Capital Advisors opened a new position in DuPont de Nemours worth $1.38M.

  • Benchmark Capital Advisors's largest Q4 2018 buy was DuPont de Nemours: 10,227 shares worth $1.38M.
  • Benchmark Capital Advisors added most to Meta Platforms (Facebook) in Q4 2018, an estimated $456K increase.
  • Benchmark Capital Advisors's biggest Q4 2018 reduction was Apple, cutting an estimated $4.43M.
  • Benchmark Capital Advisors fully exited Walgreens Boots Alliance in Q4 2018, selling an estimated $2.06M.
  • Benchmark Capital Advisors's ten largest holdings make up 36% of its $101M portfolio in Q4 2018.
  • Benchmark Capital Advisors opened 2 new positions and closed 21 in Q4 2018.
  • Benchmark Capital Advisors's portfolio value fell 24% quarter-over-quarter to $101M.

Based on Benchmark Capital Advisors's 13F filing for Q4 2018, filed 11 Feb 2019.